Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT

In this report, we present (18)F-FDG PET/CT findings of reactive left axillary and supraclavicular hypermetabolic lymphadenopathy, as well as ipsilateral deltoid muscle injection site radiotracer uptake, related to recent coronavirus disease 2019 (COVID-19) vaccination in a patient with osteosarcoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Mathew V., Yang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2021
Materias:
Teaching Case Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712634/
https://www.ncbi.nlm.nih.gov/pubmed/33820864
http://dx.doi.org/10.2967/jnmt.121.262008
_version_ 1784623595374247936
author Smith, Mathew V.
Yang, Ming
author_facet Smith, Mathew V.
Yang, Ming
author_sort Smith, Mathew V.
collection PubMed
description In this report, we present (18)F-FDG PET/CT findings of reactive left axillary and supraclavicular hypermetabolic lymphadenopathy, as well as ipsilateral deltoid muscle injection site radiotracer uptake, related to recent coronavirus disease 2019 (COVID-19) vaccination in a patient with osteosarcoma. With the growing number of patients receiving COVID-19 vaccine, recognition of benign characteristic (18)F-FDG PET/CT image findings will ensure staging and restaging accuracy and avoid unnecessary biopsy.
format Online
Article
Text
id pubmed-8712634
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Society of Nuclear Medicine
record_format MEDLINE/PubMed
spelling pubmed-87126342022-01-21 Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT Smith, Mathew V. Yang, Ming J Nucl Med Technol Teaching Case Studies In this report, we present (18)F-FDG PET/CT findings of reactive left axillary and supraclavicular hypermetabolic lymphadenopathy, as well as ipsilateral deltoid muscle injection site radiotracer uptake, related to recent coronavirus disease 2019 (COVID-19) vaccination in a patient with osteosarcoma. With the growing number of patients receiving COVID-19 vaccine, recognition of benign characteristic (18)F-FDG PET/CT image findings will ensure staging and restaging accuracy and avoid unnecessary biopsy. Society of Nuclear Medicine 2021-09 /pmc/articles/PMC8712634/ /pubmed/33820864 http://dx.doi.org/10.2967/jnmt.121.262008 Text en © 2021 by the Society of Nuclear Medicine and Molecular Imaging.
spellingShingle Teaching Case Studies
Smith, Mathew V.
Yang, Ming
Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
title Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
title_full Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
title_fullStr Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
title_full_unstemmed Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
title_short Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT
title_sort reactive axillary lymphadenopathy to covid-19 vaccination on (18)f-fdg pet/ct
topic Teaching Case Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712634/
https://www.ncbi.nlm.nih.gov/pubmed/33820864
http://dx.doi.org/10.2967/jnmt.121.262008
work_keys_str_mv AT smithmathewv reactiveaxillarylymphadenopathytocovid19vaccinationon18ffdgpetct
AT yangming reactiveaxillarylymphadenopathytocovid19vaccinationon18ffdgpetct

Ejemplares similares